Vivani Medical Inc. (VANI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vivani Medical Inc. (VANI) has a cash flow conversion efficiency ratio of -4.852x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.35 Million) by net assets ($1.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vivani Medical Inc. - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Vivani Medical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read VANI total liabilities for a breakdown of total debt and financial obligations.
Vivani Medical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vivani Medical Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Afluente Transmissão de Energia Elétrica S.A
SA:AFLT3
|
0.067x |
|
Panda Financial Holding Corp Ltd
SHG:600599
|
0.459x |
|
New Delhi Television Limited
NSE:NDTV
|
1.199x |
|
ALT5 Sigma Corporation
NASDAQ:ALTS
|
-0.006x |
|
T.K.S. Technologies Public Company Limited
BK:TKS
|
0.027x |
|
Rand Mining Ltd
AU:RND
|
0.048x |
|
Grupo Greening 2022 SA
MC:GGR
|
N/A |
|
Laiqon AG
XETRA:LQAG
|
-0.084x |
Annual Cash Flow Conversion Efficiency for Vivani Medical Inc. (2012–2024)
The table below shows the annual cash flow conversion efficiency of Vivani Medical Inc. from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Vivani Medical Inc. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $17.61 Million | $-20.79 Million | -1.180x | -3.40% |
| 2023-12-31 | $20.76 Million | $-23.70 Million | -1.142x | -169.22% |
| 2022-12-31 | $44.31 Million | $-18.79 Million | -0.424x | +90.46% |
| 2021-12-31 | $2.46 Million | $-10.95 Million | -4.443x | -13.70% |
| 2020-12-31 | $1.95 Million | $-7.62 Million | -3.907x | -2.88% |
| 2019-12-31 | $7.28 Million | $-27.63 Million | -3.798x | +60.71% |
| 2018-12-31 | $3.08 Million | $-29.81 Million | -9.666x | -218.15% |
| 2017-12-31 | $7.88 Million | $-23.95 Million | -3.038x | -35.12% |
| 2016-12-31 | $11.15 Million | $-25.07 Million | -2.248x | -121.77% |
| 2015-12-31 | $20.27 Million | $-20.55 Million | -1.014x | -105.34% |
| 2014-12-31 | $34.62 Million | $-17.09 Million | -0.494x | -126.13% |
| 2013-12-31 | $-9.22 Million | $-17.43 Million | 1.890x | -62.45% |
| 2012-12-31 | $-3.04 Million | $-15.32 Million | 5.034x | -- |
About Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatid… Read more